Genomictree Decides to Acquire 42,000 Shares of NES Biotechnology

[Asia Economy Reporter Lee Seon-ae] Genomictree announced on the 14th that it has decided to acquire 42,857 shares of NES Biotechnology through a new share cash acquisition method. The acquisition amount is 3 billion KRW, which accounts for 3.15% of the company's equity capital. After the acquisition, the shareholding ratio will be 16.92%.

This content was produced with the assistance of AI translation services.